Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
| Company Name | Founded | Funding Stage | Amount | City |
|---|---|---|---|---|
| Pepgen | 2025 | Post-IPO Equity | Undisclosed | Oxford |
| Korsana Biosciences | 2025 | Series A | Undisclosed | Waltham |
| Bigfoot Biomedical | 2022 | Convertible Note | Undisclosed | Milpitas |
| Inspirato | 2024 | Post-IPO Equity | Undisclosed | Denver |
| Compass Therapeutics | 2025 | Post-IPO Equity | Undisclosed | Boston |
| Day One Biopharmaceuticals | 2024 | Post-IPO Equity | Undisclosed | South San Francisco |
| Scorpion Therapeutics | 2024 | Series C | Undisclosed | Boston |
| Tango Therapeutics | 2026 | Post-IPO Equity | Undisclosed | Cambridge |
| Elevation Oncology | 2023 | Post-IPO Equity | Undisclosed | New York |
| Jade Biosciences | 2026 | Post-IPO Equity | Undisclosed | Waltham |
| # | Company | Stage | Amount | Location |
|---|---|---|---|---|
| 1 | Pepgen | Post-IPO Equity | Undisclosed | Oxford, United Kingdom |
| 2 | Korsana Biosciences | Series A | Undisclosed | Waltham, United States |
| 3 | Bigfoot Biomedical | Convertible Note | Undisclosed | Milpitas, United States |
| 4 | Inspirato | Post-IPO Equity | Undisclosed | Denver, United States |
| 5 | Compass Therapeutics | Post-IPO Equity | Undisclosed | Boston, United States |
| 6 | Day One Biopharmaceuticals | Post-IPO Equity | Undisclosed | South San Francisco, United States |
| 7 | Scorpion Therapeutics | Series C | Undisclosed | Boston, United States |
| 8 | Tango Therapeutics | Post-IPO Equity | Undisclosed | Cambridge, United States |
| 9 | Elevation Oncology | Post-IPO Equity | Undisclosed | New York, United States |
| 10 | Jade Biosciences | Post-IPO Equity | Undisclosed | Waltham, United States |
PepGen is empowering nucleic acid therapeutics to go the distance.
Korsana Biosciences develops THETA-enabled antibody therapies for neurodegenerative diseases including Alzheimer’s.
Bigfoot Biomedical is a medical device company changing diabetes care for people with insulin-requiring diabetes.
Inspirato is a luxury travel and lifestyle subscription company.
Compass Therapeutics is a biopharmaceutical company that focuses on drugging the immune system to treat human diseases.
Day One Biopharmaceuticals develops targeted therapies to treat people with life-threatening diseases.
Scorpion Therapeutics is a clinical-stage oncology company that specializes in precision medicine for cancer patients.
Tango Therapeutics is a biotechnology company that is developing next generation cancer therapies.
Elevation Oncology is a clinical-stage biopharmaceutical company focused on the development of precision medicines for patients.
Jade Biosciences is developing transformative therapies to redefine the standard of care for inflammation and immunology indications.
Pyxis Oncology is a biotechnology firm that develops antibody therapeutics intended to promote the body's immune response to cancer.
ALX Oncology is a preclinical stage biotechnology company developing innovative immuno-oncology therapies for cancer.
Lycia Therapeutics is a biotechnology company that focuses on developing technology that utilizes lysosome-targeting chimeras.
Helus Pharma is a biopharmaceutical company that develops psychedelic therapeutics for mental health conditions.
Entrada Therapeutics is a developer of novel therapeutics intended to treat devastating diseases.
Definium Therapeutics provides psychedelic-inspired medicines and therapies for substance abuse disorders and other mental illnesses.
Triveni Bio is a biotechnology company that develops antibody-based therapeutics for immunological and inflammatory diseases.
Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.
Parabilis Medicines is a Grupo Bugio is a biopharmaceutical firm that specializes in creating medicines.
Shattuck Labs is a biotechnology company that provides novel class biologic medicines for the treatment of cancer and autoimmune disease.
Ocugen is a biotechnology company that develops novel gene and cell therapies to improve health and patient outcomes.
ITeos Therapeutics is a biotechnology company that specializes in tumor immunology, cancer immunotherapy, and drug discovery.
Wallbox is a technology company that provides electric vehicle charging and energy management solutions.
Forte Biosciences is a biotechnology company that focuses on dermatology.
IntelyCare is revolutionizing healthcare staffing, scheduling, and training by offering an enterprise workforce management platform.
Janus Henderson Investors has invested in 175 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Janus Henderson Investors's top investment sectors include Biotechnology, Health Care, Biopharma, Medical, Pharmaceutical. The firm invests across 34 different industry categories.
Among tracked funding rounds, Parabilis Medicines received $305.0M in a Post-IPO Equity round. Janus Henderson Investors's total known invested capital is $12.5B.
Janus Henderson Investors's average investment size is $129.0M across its portfolio of 175 companies.
Recent Janus Henderson Investors portfolio additions include Pepgen, Korsana Biosciences, Bigfoot Biomedical, Inspirato, Compass Therapeutics. These companies were founded in 2020 or later.
Discover portfolio companies of other leading venture capital firms and investors.
View All Investors